These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3063158)

  • 1. Osteogenesis imperfecta: the molecular basis of clinical heterogeneity.
    Byers PH; Bonadio JF; Cohn DH; Starman BJ; Wenstrup RJ; Willing MC
    Ann N Y Acad Sci; 1988; 543():117-28. PubMed ID: 3063158
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteogenesis imperfecta, but which one?].
    Guibaud P
    Pediatrie; 1990; 45(12):839-43. PubMed ID: 1963931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta.
    Byers PH; Steiner RD
    Annu Rev Med; 1992; 43():269-82. PubMed ID: 1580589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the molecular pathology of osteogenesis imperfecta.
    Cole WG; Jaenisch R; Bateman JF
    Q J Med; 1989 Jan; 70(261):1-4. PubMed ID: 2687927
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteogenesis imperfecta: translation of mutation to phenotype.
    Byers PH; Wallis GA; Willing MC
    J Med Genet; 1991 Jul; 28(7):433-42. PubMed ID: 1895312
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in osteogenesis imperfecta.
    Cole WG
    Clin Orthop Relat Res; 2002 Aug; (401):6-16. PubMed ID: 12151877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed triple-helix formation of abnormal type I collagen is corrected by reduced temperature. Studies of a family with variable expression of osteogenesis imperfecta.
    Superti-Furga A; Royce PM; Pistone FM; Romano C; Steinmann B
    Ann N Y Acad Sci; 1988; 543():85-92. PubMed ID: 3214056
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene symbol: COL1A2. Disease: osteogenesis imperfecta type II.
    Tinkle BT; Miller E; Schorry EK
    Hum Genet; 2006 Jul; 119(6):677. PubMed ID: 17128474
    [No Abstract]   [Full Text] [Related]  

  • 9. Normal thermal stability of an overmodified type I collagen despite a structural mutation within the triple helical region in a case of osteogenesis imperfecta type IVB.
    Royce PM; Superti-Furga A; Rao VH; Steinmann B
    Ann N Y Acad Sci; 1988; 543():83-4. PubMed ID: 3214055
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and genetical heterogeneity of osteogenesis imperfecta.
    Maroteaux P; Cohen-Solal L; Bonaventure J
    Ann N Y Acad Sci; 1988; 543():16-29. PubMed ID: 3063162
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel glycine to glutamic acid substitution at position 343 in the alpha 2 chain of type I collagen in an individual with lethal osteogenesis imperfecta.
    Rose NJ; Mackay K; Byers PH; Dalgleish R
    Hum Mol Genet; 1993 Dec; 2(12):2175-7. PubMed ID: 7906591
    [No Abstract]   [Full Text] [Related]  

  • 12. Lethal mutations in type I collagen: structure-function relationships in the type I collagen molecule.
    Byers PH; Bonadio JF
    Birth Defects Orig Artic Ser; 1984; 20(3):65-77. PubMed ID: 6391576
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel G1006A substitution in the alpha 2(I) chain of type I collagen produces osteogenesis imperfecta type III.
    Lu J; Costa T; Cole WG
    Hum Mutat; 1995; 5(2):175-8. PubMed ID: 7749416
    [No Abstract]   [Full Text] [Related]  

  • 15. Exclusion of the alpha 1(II) cartilage collagen gene as the mutant locus in type IA osteogenesis imperfecta.
    Sykes B; Smith R; Vipond S; Paterson C; Cheah K; Solomon E
    J Med Genet; 1985 Jun; 22(3):187-91. PubMed ID: 2989526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe osteogenesis imperfecta: type 1 collagen abnormalities in 17 skin fibroblast cell lines.
    Pocock AE; Francis MJ; Smith R
    Biochem Soc Trans; 1991 Nov; 19(4):382S. PubMed ID: 1794514
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
    Radmer RJ; Klein TE
    Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity.
    Sillence DO; Rimoin DL; Danks DM
    Birth Defects Orig Artic Ser; 1979; 15(5B):113-29. PubMed ID: 393318
    [No Abstract]   [Full Text] [Related]  

  • 19. General strategies for isolating the genes encoding type I collagen and for characterizing mutations which produce osteogenesis imperfecta.
    Cohn DH; Wenstrup RJ; Willing MC; Bonadio JF; Byers PH
    Ann N Y Acad Sci; 1988; 543():129-35. PubMed ID: 3063159
    [No Abstract]   [Full Text] [Related]  

  • 20. Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online.
    Mottes M; Gomez Lira M; Zolezzi F; Valli M; Lisi V; Freising P
    Hum Mutat; 1998; 12(1):71-2. PubMed ID: 10627137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.